This Men’s Health Month, tune in to the latest CPD Podcast episode as Emma Jardine, AFASA is joined by Dr Pamela Parker, Consultant Sonographer and former President of the British Medical Ultrasound Society, to discuss the evolving role of micro-ultrasound (microUS) in prostate cancer care. From its potential as an alternative to MRI in active surveillance to the real-world challenges of implementation, Dr Parker shares insights from her clinical practice and research.
🎧 Listen now: loom.ly/QPqRBYQ#SupportingSonographers
🚨 New publication!
#microUS demonstrated diagnostic performance comparable to #mpMRI in 457 patients undergoing prostate biopsy. The real question: are they competitors, or complementary tools detecting different aspects of cs #ProstateCancer?
@ExactImaging@ab_medica@hpg23bg
Moisés Rodríguez Socarrás demonstrated microUS-guided focal cancer treatment combined with HoLEP — a live glimpse of where anatomical enucleation meets focal prostate oncology.
In front of 75 urologists. 3/7
ostate cancer screening is evolving fast.
📌 mpMRI remains the standard, reducing unnecessary biopsies by >70% and lowering detection of indolent cancers.
📌 bpMRI showed non-inferior detection vs mpMRI (PRIME trial) with faster, cheaper workflows.
📌 AI-assisted MRI reading (PI-CAI) achieved 50% fewer false positives.
📌 Emerging tools like microUS and PSMA PET/CT may further refine risk stratification and biopsy avoidance. #AUA26
Good morning #AUA26
Come join us in 145AB at 7AM
We’ll be talking about #ProstateCancer Detection and Screening
✅microUS and image stacking
✅AI and POC path diagnostics
✅PSMA PET for diagnosis
✅costs of omitting systematic biopsy
@CleClinicUro@hjwang26@drjkaouk
Congratulations @Rafa_Borges9 on your continuous effort. Excellent manuscript addressing the powerful symbiosis between MicroUS and MRI for csPCa detection.
Detection of Clinically Significant Prostate Cancer Using Micro-Ultrasound Versus MRI/Ultrasound Fusion Biopsy: A Propensity-Weighted Comparative Study Great work by Rafael Castilho Borges and @rafaeltourinho MicroUS is a sound option in diagnosis auajournals.org/doi/epdf/10.…
“MicroUS is a Canadian innovation success story.” #UofT alum Dr. Laurence Klotz led a new study showing high-resolution ultrasound is as effective as MRI in detecting prostate cancer, paving the way for faster, more accessible diagnoses. Find out more: bit.ly/44dsQTB
Our new study evaluated diagnostic outcomes of MRI-US fusion targeted biopsy for #PCa detection using either MicroUS or conventional US.
Grateful to my mentors, co-authors and @Yale_Urology for their contributions and support!
@mleapman@SoumLokeshwar@gabrielamdd@ankurologie
🔬 #EAU25 – Jour 3 : Les faits marquants ! 🔬
💡 Rein :
🇫🇷 La France brille au #UroCCR avec 13 abstracts !
📊 Dépistage du CCR : acceptabilité élevée (96,1 % sans regret), coût-efficace et 1/50 cancers détectés.
🛠 Lithiase :
💨 Aspiration > mesure du volume des fragments ? Débat relancé !
🆕 Glitz et CVAC en test : révolution ou complications ?
🔬 Prostate :
🚫 TRANSLATE : fin actée de la voie transrectale pour les biopsies.
🎯 OPTIMUM : microUS ≈ IRM pour détecter les CaP cliniquement significatifs.
📉 ARNEO : ajout d’apalutamide en néoadjuvant ? Pas d’impact majeur.
🔥 Urothélial :
🦠 ctDNA pré-cystectomie : biomarqueur clé de la récidive !
🔪 Curage ganglionnaire maximal essentiel pour le pronostic. Robot vs ouvert = pas de différence.
🦠 Infectiologie :
💊 APPEAL trial : prophylaxie antibiotique en ESWL ? Cipro ↓ urosepsis (0 vs 1,2 %, p=0.003), mais pas d’impact sur ITU symptomatiques.
➡️ #Urology#MedTwitter@FUTUR_AFU@Uroweb@MRoupret